Insider · CIK 0001197350

BJERKHOLT ERIC

Reports to the SEC for 10 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001197350

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,943 sh	$98.37	−$978K	44,745
2026-09-11	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−18.3K sh	—	—	0
2026-09-11	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+18.3K sh	—	—	54,688
2026-08-11	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−6,001 sh	$99.90	−$600K	36,355
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,124 sh	$121.67	−$380K	44,057
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−300 sh	$124.94	−$37.5K	42,181
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−528 sh	$123.84	−$65.4K	42,481
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,048 sh	$122.43	−$128K	43,009
2026-06-09	CERSCERUS CORPS Sale	Director	SSale	−20.5K sh	$2.60	−$53.2K	261,679
2026-06-09	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,393 sh	$26.49	+$63.4K	47,181
2026-06-09	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,393 sh	—	—	26,653
2026-06-09	MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	21,000
2026-06-08	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,258 sh	$92.84	−$210K	47,530
2026-06-08	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,567 sh	$95.12	−$149K	44,788
2026-06-08	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,175 sh	$93.95	−$110K	46,355
2026-06-02	CERSCERUS CORPA Award	Director	AAward	+60K sh	—	—	282,133
2026-05-13	SRZNSurrozen, Inc./DE · Director Stock Option (right to buy)A Award	Director	AAward	+5,550 sh	—	—	5,550
2026-03-16	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−7,287 sh	$91.98	−$670K	49,788
2026-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−13.3K sh	—	—	6,666
2026-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+13.3K sh	—	—	57,075
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+18.1K sh	—	—	18,140
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+11.8K sh	—	—	11,760
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+20K sh	—	—	20,000
2026-01-26	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,053 sh	$96.19	−$101K	43,741
2026-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,667 sh	—	—	2,666
2026-01-23	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,667 sh	—	—	44,794
2026-01-22	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,421 sh	$93.33	−$133K	42,127
2026-01-21	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+3,334 sh	—	—	43,548
2026-01-21	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−3,334 sh	—	—	6,666
2025-09-12	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,578 sh	$76.01	−$728K	39,945
2025-09-11	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+18.3K sh	—	—	49,523
2025-09-11	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−18.3K sh	—	—	18,333
2025-08-12	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,954 sh	$26.49	+$78.3K	31,190
2025-08-12	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,954 sh	—	—	29,046
2025-08-11	MIRMMirum Pharmaceuticals, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−8,000 sh	—	—	28,236
2025-06-10	MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,572 sh	—	—	8,572
2025-06-03	CERSCERUS CORPA Award	Director	AAward	+60K sh	—	—	222,133
2025-05-14	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director	AAward	+1,333 sh	—	—	1,333
2025-02-03	MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2025-01-23	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,667 sh	—	—	35,946
2025-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,667 sh	—	—	5,333
2025-01-21	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+10K sh	—	—	10,000
2025-01-21	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+40K sh	—	—	40,000
2024-12-12	CERSCERUS CORPS Sale	Director	SSale	−20K sh	$1.78	−$35.7K	162,133
2024-11-08	MIRMMirum Pharmaceuticals, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+475 sh	$21.05	+$9,996.85	33,279
2024-09-11	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−18.3K sh	—	—	36,666
2024-09-11	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+18.3K sh	—	—	32,804
2024-08-27	CALCCalciMedica, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-06-05	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director	AAward	+1,333 sh	—	—	1,333
2024-06-05	CERSCERUS CORPA Award	Director	AAward	+40K sh	$5.00	+$200K	182,133

Recent filings

Accepted (ET)
Sep 154
BJERKHOLT ERIC0001197350-26-000010
SEC(opens sec.gov)
Aug 124
BJERKHOLT ERIC0001197350-26-000009
SEC(opens sec.gov)
Jul 84
BJERKHOLT ERIC0001197350-26-000008
SEC(opens sec.gov)
Jun 114
BJERKHOLT ERIC0001193125-26-268227
SEC(opens sec.gov)
Jun 114
BJERKHOLT ERIC0001193125-26-267189
SEC(opens sec.gov)
Jun 94
BJERKHOLT ERIC0001197350-26-000007
SEC(opens sec.gov)
Jun 24
BJERKHOLT ERIC0001193125-26-254116
SEC(opens sec.gov)
May 144
BJERKHOLT ERIC0001193125-26-224131
SEC(opens sec.gov)
Mar 174
BJERKHOLT ERIC0001197350-26-000006
SEC(opens sec.gov)

Companies

Address

C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300

FOSTER CITY, CA, 94404